Multiple Myeloma

This week’s episode we are back with our very special guest, friend and colleague Dr Laura Vater joining us to talk about wellness in oncology, and burnout prevention tips. 

This week’s episode we have a very special guest, friend and colleague Dr. Laura Vater joining us to talk about one of the biggest transitions in medicine—moving from fellow to attending.Dr Vater is a GI oncologist at IU, writer, and speaker. She focuses on the dignity of patient ... Show More

This week’s episode will be focusing on an ASCO 2026 Plenary abstract, SARC 041. SARC041 is the first positive phase 3 randomized controlled trial of a CDK4/6 inhibitor in advanced dedifferentiated liposarcoma (DDLPS), demonstrating that abemaciclib significantly improves progres ... Show More

<p class="" style="white-space:pre-wrap;">In this continuation of our myeloma series, we discuss the progression of MGUS &amp; smoldering myeloma to multiple myeloma. We also outline how to risk stratify a patient with multiple myeloma and gauge their response to treatment.&nbsp; ... Show More

<p class="" style="white-space:pre-wrap;">In this continuation of our myeloma series, we build on our prior discussion about myeloma pharmacology, this time discussing how to select the optimal regimen for treatment of our patients.</p><p class="" style="white-space:pre-wrap;">Co ... Show More

<p>In this episode I cover myeloma.<br/><br/>If you want to follow along with written notes on myeloma go to <a href='https://zerotofinals.com/medicine/haematology/myeloma/'>zerotofinals.com/medicine/haematology/myeloma/</a> or the haematology section in the Zero to Finals medici ... Show More

Send us Fan MailNinja Nerds!Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we take a closer look at Plasma Cell Disorders, focusing on their pathophysiology, clinical features, and management. Topics include the mechanisms behind multiple myeloma, monoclona ... Show More

<p>This episode covers myeloma.<br/><br/>Written notes can be found at <a href='https://zerotofinals.com/medicine/haematology/myeloma/'>https://zerotofinals.com/medicine/haematology/myeloma/</a> or in the haematology section of the 2nd edition of the Zero to Finals medicine book. ... Show More

In this week's episode, we’ll learn more about mechanisms of primary resistance to BCMA-targeted bispecific T-cell engagers in relapsed/refractory multiple myeloma, the effects of emapalumab therapy on outcomes in patients with pediatric hemophagocytic lymphohistiocytosis who rec ... Show More

<p class="" style="white-space:pre-wrap;">In this continuation of our myeloma series, we begin our discussion about treatment options for multiple myeloma, focusing first on pharmacology. We are so thrilled to have a special guest, Kathryn Maples, PharmD, BCOP who is a clinical p ... Show More

<p>In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ... Show More

This episode is a continuation of the Hematology and Oncology chapter of Crush Step 1. Content covered includes: - Lymphomas - Histiocyte Disorders (Langerhans Cell Histiocytosis [LCH] and Histiocytosis X) - Plasma Cell Disorders (Multiple Myeloma, Waldenström Macroglobulinemia [ ... Show More

Joseph Mikhael, MD, and Peter Voorhees, MD, discuss frontline therapy for multiple myeloma and new options for both transplant-eligible and transplant-ineligible patients. Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/view ... Show More